Barclays »

Camp4 Therapeutics Corp shares owned by Barclays

Quarter-by-quarter ownership of Camp4 Therapeutics Corp (CAMP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Camp4 Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Camp4 Therapeutics Corp held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Camp4 Therapeutics Corp by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $210 70 3.00
2025-03-31 $30k 7.5k 4.00
2024-12-31 $55k 11k 5.15

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Camp4 Therapeutics Corp

5AM Venture Management
Henderson Group
Vivo Capital
Enavate Sciences GP
FMR
AH Capital Management
Adage Capital Partners GP
HarbourVest Partners
Silverarc Capital Management
Vanguard Group
Alyeska Investment Group
Two Sigma Investments
Millennium Management
Victory Capital Management
Geode Capital Management

View all funds holding Camp4 Therapeutics Corp